TKIs - Globe Thesis - Globe Thesis

Keyword [TKIs] Result: 101 - 120 \| Page: 6 of 10
101.	Expressions And Clinical Significance Of Notch1 And IGF-1 In Different EGFR Gene Status Of Non-small Cell Lung Cancer
102.	The Systematic Review And Medication Rules Of Traditional Chinese Medicine Combined With EGFR-TKIs In The Treatment Of Non-small-Cell Lung Carcinoma
103.	Relationship Between BIM Deletion Polymorphism And The Curative Effect Of EGFR-TKIs In Advanced NSCLC Patients With EGFR Positive Mutations:A Meta-analysis
104.	Mechanisms Of EGFR-TKIs Acquired Resistance Induced By NEDD4 In Non-small Cell Lung Cancer
105.	Metformin Sensitizes EGFR-TKIs Primary Resistant Human Lung Cancer Cells Through Inhibition Of IGF-1R Signaling And EMT Reversal
106.	The Function Of IGF-1R In MiR-223 Mediated Erlotinib Resistance In Non-small Cell Lung Cancer
107.	Treatment Strategies To Acquired Resistance Of EGFR-TKIs In Non-small-cell Lung Cancer Patients
108.	The Expression Of MiRNA-1 Regulated By Paclitaxel In EGFR-TKIs Resistant Lung Cancer
109.	Efficacy And Safety Of Stereotactic Body Radiation Therapy In The Management Of Oligopersistent Disease In Patients With Egfr Mutant Non-small Cell Lung Cancer During EGFR-TKIs Treatment
110.	Acquired EGFR-TKIs Resistance In Non-small Lung Cancer By Lysosomal Deficiency-induced SQSTM1 Accumulation
111.	Apatinib With Gefitinib Or Icotinib For Advanced Non-small Cell Lung Cancer Patients With Acquired Resistance To First-generation EGFR-TKIs
112.	AP Versus DP Chemotherapy Regimen As Second-line Therapy In EGFR-TKIs Treated Advanced Non-small-cell Lung Cancer Patients With EGFR Mutations
113.	A Retrospective Study Of The Characteristics Of Chinese Medicine Combined With EGFR-TKIs To Delay The Late NSCLC Resistance Time
114.	Investigation On The Predictor Of Efficacy For EGFR-TKIs And Platinum-based Chemotherapy In Advanced Non-small Cell Lung Cancer And Their Drug Resistance Mechanisms
115.	An In-vitro Study Of Acquired Resistance To Irreversible EGFR-TKIs In Non-small Cell Lung Cancer
116.	The Clinical Study And The Mechanism On The Reversion Of Acquired Resistance With The First Generation EGRF-TKIs For Advanced NSCLC Patients
117.	Preliminary Study Of Exon Sequence In Pneumoconiosis Using High-throughput And Intervention Of EGFR-TKIs On Silicosis
118.	Study Of Relation Between PD-L1 Expression And EGFR-TKIs Resistance Mechanism In Non-small Cell Lung Cancer
119.	Inhibition Of Nuclear Factor-kB Improves Sensitivity To Irradiation And EGFR-TKIs,and Decreases Irradiation-induced Lung Toxicity
120.	Molecular Mechanisms Of Tyrosine Kinase Inhibitor Resistance Induced By Cytoplasmic/Nuclear Translocation Of Epidermal Growth Factor Receptor
<<First <Prev Next> Last>> Jump to